Board of Registration in Nursing

Slides:



Advertisements
Similar presentations
The Pharmaceutical Agent Order. Prescription An oral or written record of a physicians order to pharmacist to dispense medication to patient.
Advertisements

Angela Singh, PharmD Assistant Professor of Pharmacy FAMU COPPS IPPE I
National Adult Clozapine Titration Chart
Changes in APRN Prescriptive Authority SB 406 Kathy Hutto Governmental Affairs Consultant Jackson Walker L.L.P. 1.
1 Board of Registration in Nursing. 2 Module 2: Standards for Conduct 244 CMR 9.00.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
Confidential 1 Electronic Prescribing of Controlled Substances (EPCS) Part 1 of a 3 Part Series Chuck Klein, Ph.D. GM/Director, Medication Management.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
Pharmacology Information, Rules, and Laws For Medications
U.S. Department of Justice Drug Enforcement Administration Office of Diversion Control Electronic Prescriptions for Controlled Substances Michelle Ferritto,
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
1 Board of Registration in Nursing. 2 Module 4: Competence: A Legal Requirement for Advanced Registered Nursing Scope of Practice.
Health and Wellness for all Arizonans azdhs.gov Arizona Association for Home Care Presentation Arizona Department of Health Services July 25, 2015.
2 H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental Health Services Administration.
1 Board of Registration in Nursing. 2 Module 3: Preparing for Practice as an Advanced Practice Registered Nurse (APRN): Board Authorization.
1 Board of Registration in Nursing. 2 Module 1: Introduction to the Massachusetts Board of Registration in Nursing and the Regulation of Advanced Practice.
The Nurse Practice Act.  Defines the Nurse Practice Act and its function  Describes how the Nurse Practice Act applies to the RN Scope of Practice Objectives.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 4 Prescription Writing.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
California State Board of Pharmacy Continuing Education Program Senate Bill 151 (Burton)
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.
Uintah School District Health Requirements and Services: Medical Treatment.
Medical Law and Ethics Lesson 3: Documentation and Regulations.
Chapter 1. OBJECTIVES  see p-2 of text book KEY TERMS / CONCEPTS  controlled substances  Drug Enforcement Administration (DEA)  drug standards  Food.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
MEDICATION ADMINISTRATION Topic 1A Drug Schedules.
April 15 th is not just the deadline for your taxes!!! Is your documentation complete for Pharmacist to Registered Technician Ratios? Policies.
Chapter One. Drug Standards- rules set to assure consumers that they get what they pay for; all preparations called by the same drug name.
SCOPE OF PRACTICE: NURSING IN OHIO Pamela S. Dickerson, PhD, RN-BC, FAAN
CHAPTER 1 The Nursing Process and Drug Therapy Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
ACCESS TO MEDICINES - POLICY AND ISSUES
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
LECTURE FOR ASSIGNMENT 1 AND 2
Copyright © 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 23 and 24 Basic Pharmacology Medication Calculations Dosage.
Rachelle S. Mercier, Esq., MPH November 6, PMP – What is it? A system that records schedule II-V medications that patients have been prescribed.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
Intro to OBRA and the Nursing Assistant. INTRODUCTION  You need to know:  What you can and cannot do  What conduct is right & wrong  Your legal limits.
Joseph R. Sabino, MS, RPh
Community Development Department Pain Management Clinics Potential Local Regulations City Council Workshop September 13, 2011.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
Drug Scheduling ● This chapter will focus on the deadliest to the least addictive drugs ● There will be a test, so study.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Physician assistants and Advanced practice Nurses who are they?
April 15th is not just the deadline for your taxes
Georgia Nurse Protocol Agreement
Quick Regulatory Guide
Drugs and Prescription Records
Drugs and Prescription Records
Updates Regarding New Physician Assistant Rules
Susan y swart Ed.D, rn, cae Executive director Ana-Illinois
REGULATION OF APRN PRACTICE IN S.C.
REGULATION OF APRN PRACTICE IN S.C.
Complete a legally valid prescription.
Federal Regulations requirements for opioid prescription course
PRESCRIPTIONS Chap. 5.
Legal Aspects Affecting the Administration of Medications
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
Update on APRN Telepractice: The Regulatory Perspective
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Illinois Prescription Monitoring Program
Ch 18: Pharmacy.
Prescriptive Authority for Nurse-Midwives in Georgia
Controlled Substances
OSU Controlled Substances Training Module for Researchers
Presentation transcript:

Board of Registration in Nursing

Module 5 Guidelines: Preparing for Advanced Practice Registered Nurse Prescriptive Practice

Prescriptive Practice Requirements Board authorization as APRN A minimum of 24 contact hours in pharmacotherapeutics beyond those acquired in generic nursing education program Valid registration(s) to issue written or oral prescriptions or medication orders from Massachusetts Department of Public Health, Drug Control Program for schedule VI and from US Drug Enforcement Administration for schedule II – V

M.G.L. 112, s. 80E, 80G, 80H Legal authorization for APRN to issue written prescriptions and order tests and therapeutics pursuant to guidelines mutually developed and agreed upon by the nurse and the supervising physician in accordance with regulations promulgated jointly by the board and the board of registration in medicine CNM are exempt from the requirement for supervising physician and guidelines CNS do not have prescriptive authority in MA A prescription made by an CNP, CRNA, PCNS must include the name of the physician with whom such nurse has developed and signed mutually agreed upon guidelines

M.G.L. 94C – Controlled Substances Act “Controlled substance” is defined as a drug, substance, or immediate precursor in any schedule or class Massachusetts statute http://www.mass.gov/legis/laws/mgl/gl-94c-toc.htm

Title 21 – Food and Drugs Chapter 13 Drug Abuse Prevention and Control Division of Food and Drugs Federal statutes http://uscode.house.gov/download/pls/21C13.txt

Prescription Schedules Schedule I (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has no currently accepted medical use in treatment in the United States. (C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.

Schedule II (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence. No prescription for a controlled substance in schedule II may be refilled.

Schedule III (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. Such prescriptions may not be filled or refilled more than six months after the date thereof or be refilled more than five times after the date of the prescription unless renewed by the practitioner.[

Schedule IV (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III. Control measures are similar to Schedule III. Prescriptions for Schedule IV drugs may be refilled up to five times within a six month period.

Schedule V (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV. No controlled substance in schedule V which is a drug may be distributed or dispensed other than for a medical purpose

Schedule VI Massachusetts designated schedule for all prescription medications that do not fall into Scheduled I - V

105 CMR 700.000 Massachusetts regulations Implementation of 94C Definitions Registration requirements Security requirements http://www.mass.gov/Eeohhs2/docs/dph/regs/105cmr700.pdf

105 CMR 721.000 Standards for prescription format and security the registration number of the practitioner; date of issuance of the prescription; name, dosage, and strength per dosage unit of the controlled substance prescribed, and the quantity of dosage units; name and address of the patient, except in a veterinary prescription; directions for use, including any cautionary statements required; and a statement indicating the number of times to be refilled. http://www.mass.gov/Eeohhs2/docs/dph/regs/105cmr721.pdf

In addition……. Paper prescriptions written by CNP, CRNA, PCNS must also contain the name of the supervising physician.

Other Requirements Special security standards for paper (review 105 CMR 721.000) Indication that “Interchange is mandated unless the practitioner indicates ‘no substitution’ in accordance with the law” The name and address of the practitioner must be clearly indicated on the prescription A hospital or clinic prescription must have the name and address of the hospital or clinic clearly indicated on the prescription

CNP, CRNA, PCNS Required to Have Prescriptive Practice Guidelines CNM exempt from guideline requirement CNS do not have prescriptive authority in MA Board may request at any time an opportunity to review the APRN’s prescriptive practice guidelines.

Content of Guidelines identify the supervising physician and APRN; include a defined mechanism for the delegation of supervision to another physician including, but not limited to, duration and scope of the delegation; describe the nature and scope of the APRN's prescribing practice; identify any limitations on medications or intravenous therapy to be prescribed; describe circumstances in which physician consultation or referral is required for the pharmacologic treatment of medical conditions; include a defined mechanism and time frame to monitor prescribing practices; specify that the initial prescription of Schedule II drugs must be reviewed within 96 hours; be kept on file in the workplace and be reviewed and re-executed every two years; and conform to M.G.L. c. 94C, the regulations of the Department of Public Health at 105 CMR 700.000 et seq., 105 CMR 721.000 et seq., M.G.L. c. 112, §§ 80B, 80C, 80E, 80G, 80H, and 244 CMR 4.00. Audit tool located at: http://www.mass.gov/eohhs/docs/dph/quality/boards/apnaudit.pdf

Educational Requirement As of January 1, 2011, pursuant to MGL 94C, Section 18(e), all prescribers, upon initial application for MA Controlled Substance Registration (MCSR) and subsequently during each APRN license renewal period, must complete education relative to: effective pain management, identification of patients at high risk for substance abuse, and counseling patients about the side effects, addictive nature and proper storage and disposal of prescription medications. Please note that MGL 94C, Section 18(e) does not specify a minimum number of contact hours to comply with this education requirement. All continuing education offerings must be consistent with the Board of Registration in Nursing (Board) requirements at 244 CMR 5.00: Continuing Education and, for this specific requirement, the Board Advisory Ruling #0901: Management of Pain.

Read What You Sign By signing the MCSR form and by your signature on your license renewal form, you attest under penalties of perjury that you have complied with state tax and child support laws, mandatory reporting laws, and all Board laws and regulations, including continuing education requirements.

Changing Supervising Physician? If guidelines have not expired, either amend with new, dated signatures of APRN and supervising physician or write and sign new guidelines Must contact MA Department of Public Health, Drug Control Program to amend MA Controlled Substance Registration

Changing Practice Location? Must contact Drug Enforcement Agency (DEA) to amend form

Prescription Monitoring Program (PMP) tool that supports safe prescribing and dispensing and assists in addressing prescription drug misuse and abuse collects prescribing and dispensing information on Massachusetts Schedule II through V controlled substances dispensed pursuant to a prescription utilizes PMP data to determine prescribing and dispensing trends provides patient prescription history information to prescribers and dispensers provides educational information to health care providers and the public provides case information to regulatory and law enforcement agencies concerning drug distribution and diversion www.mass.gov/dph/dcp/onlinepmp

Prescription Monitoring Program (PMP) Prescribers will be automatically enrolled into program upon initial or renewal of MA Controlled Substance Registration (MCSR)

Legal Documentation In all records required by federal and state laws and regulations and accepted standards of nursing practice Must be accurate, complete, legible Sign name and initials as they appear on your license (CNP, PCNS, CRNA, CNM, CNS) May use certification credentials on business cards, stationary, advertisements, and other similar correspondence

MA Controlled Substance Registration (MCSR) Contact the Drug Control Program through the Department of Public Health www.mass.gov/dph/dcp

Federal Drug Enforcement Agency Federal Registration Contact the Federal Drug Enforcement Agency http://www.justice.gov/dea

Review 4.00 and 9.00 Go to the Board’s website to review: 244 CMR 4.00: Massachusetts Regulations Governing Advanced Practice Registered Nursing 244 CMR 9.00: Standards of Conduct

Get into the habit of Checking the Board’s Website www.mass.gov/dph/boards/rn News and Updates Practice Issues Alerts Regulatory Guidance Advisory Rulings Newsletters